HEOR News Roundup

Tuesday, August 13, 2019 | Issue 464

Subscribe Contact Advertise HEOR & RWE Marketplace

Sponsored by

ICER: Zolgensma Review Not
Compromised by Data Issue

ICER said recent issues with animal testing data for Novartis’ Zolgensma will not require an updated review of the initial assessment.

Read More

Analyst: Congress Likely to Pass Drug Pricing Bill Ahead of 2020 Election

AstraZeneca to Use Inovalon’s ONE Platform for New Initiative

PCORI Awards Grant to HFA

ICER Holds Public Meeting on DMD Treatments




340B Manufacturer Summit

August 20-21 | Alexandria, Virginia




From Big Data to Rapid Analytics for Rheumatology - Data Quality, Tools, and Usage

August 14

Syndicated Reports
Biosimilars: US Payer Insights (2019)
Review of Influence: The Institute for Clinical and Economic Review
White Papers
Leveraging Technology to Reduce Costs in Clinical Trials
Evidence Generation and Communication
  Market Access Writer 1
(Entry Level) London
Entry-Level Market Access Communications Writer Associate Director/Lead Market Access Writer Lead Market Access Writer

Share this newsletter!